Notation to File

NOTE TO THE FILE

SERIAL NUMBER:            90056846

DATE:                                11/16/2020

NAME:                               thardy

NOTE:         

Searched:                                                             
     Google                            
     Lexis/Nexis                       
     OneLook
     Wikipedia
     Acronym Finder                         Protest evidence reviewed
     Other:

Checked:                                                             
     Geographic significance          
     Surname                          
     Translation
     ID with ID/CLASS mailbox

     Checked list of approved Canadian attorneys and agents

Discussed file with
Attorney/Applicant via:
        phone                               Left message with
        email                               Attorney/Applicant

     Requested Law Library search       X   Issued Examiner’s Amendment
     for:                                   and entered changes in TRADEUPS

        PRINT        DO NOT PRINT           Added design code in TRADEUPS
     Description of the mark
     Translation statement                  Re-imaged standard character
                                            drawing
     Negative translation statement             
     Consent of living individual           Contacted TM MADRID ID/CLASS
                                            about misclassified definite ID
     Changed TRADEUPS to:

 X   OTHER:

U.S. Trademark Application No. 90056846

Mark:  VYNE THERAPEUTICS

International Class:  5

Applicant:  VYNE Pharmaceuticals Ltd

Attorney Docket:  13949.3035

 

Hi Tarah,

 

I am writing in response to the November 4, 2020 Priority Action issued in this application. I’m sorry that I was unable to provide you with instructions earlier, but we have now received our client’s input on the two issues raised in the Priority Action. Hopefully you can issue an Examiner’s Amendment, entering the following amendments to the application:

 

• The applicant consents to the disclaimer of the term “THERAPEUTICS” apart from the mark as shown.

 

• The applicant wishes to amend the identification of goods in Class 5 to “Pharmaceutical preparations for use in the treatment of inflammatory disorders; dermatological pharmaceutical preparations.”

 

If you have any questions, please do not hesitate to contact me by e-mail or phone. Otherwise, I look forward to receiving an Examiner’s Amendment in due course.

 

Best regards,

 

Christie

 

Christie Baty Hudgins

Of Counsel

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

901 New York Avenue NW, Washington, DC 20001

Direct: 202.408.4040 | Fax: 202.408.4400 | Mobile: 404.606.2230

christie.hudgins@finnegan.com | www.finnegan.com

 

_______________________________________________­____

 

 

From: Hudgins, Christie Baty <christie.hudgins@finnegan.com>
Sent: Thursday, October 29, 2020 11:40 AM
To: Hardy, Tarah <Tarah.Hardy@USPTO.GOV>
Cc: Ruff, Daniel <daniel.ruff@finnegan.com>
Subject: RE: U.S. Trademark App. No. 90056846 - Informal Inquiry

 

Tarah,

 

Thanks for reaching out. I will contact my client for instructions and hopefully I can get back to you within a few days so you can enter any amendments via Examiner’s Amendment. If I don’t get back to you with instructions before you need to take action on the application, then please go ahead and issue a written Office Action.

 

Regards,

 

Christie

 

Christie Baty Hudgins

Of Counsel

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

901 New York Avenue NW, Washington, DC 20001

Direct: 202.408.4040 | Fax: 202.408.4400 | Mobile: 404.606.2230

christie.hudgins@finnegan.com | www.finnegan.com

 

_______________________________________________­____

 

 

From: Hardy, Tarah <Tarah.Hardy@USPTO.GOV>
Sent: Wednesday, October 28, 2020 6:07 PM
To: Docket Updates <Docketupdates@finnegan.com>
Subject: U.S. Trademark App. No. 90056846 - Informal Inquiry

 

EXTERNAL Email:

 

Hello,

 

I am currently examining the trademark application for the mark VYNE THERAPEUTICS, Attny. Doc. # 13949.3035.  No conflicting marks were found.  However, before the mark can proceed to publication a few items need to be addressed.

 

1. A disclaimer of the  term THERAPEUTICS needs to be made of record.
2. The ID needs to be modified to comply with office format.  I suggest the following if accurate:

 

Pharmaceutical preparations for use in the treatment of __________ [specify condition (e.g. headaches)]; dermatological pharmaceutical preparations, in International Class 5.

 

I can make these changes through examiner’s amendment and then approve the mark for publication.  I look forward to your prompt response.

 

Sincerely,

 

Tarah Hardy Ludlow

Trademark Attorney

USPTO - Law Office 110

571-272-9361

 

This e-mail message is intended only for individual(s) to whom it is addressed and may contain information that is privileged, confidential, proprietary, or otherwise exempt from disclosure under applicable law. If you believe you have received this message in error, please advise the sender by return e-mail and delete it from your mailbox. Thank you.